Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1)

Campos, Karoline Rodrigues; Gonçalves, Maria Gisele; Costa, Nadia Aparecida; Caterino-de-Araujo, Adele.
Braz. j. infect. dis ; 21(3): 297-305, May-June 2017. tab
Artigo em Inglês | LILACS | ID: biblio-839207

Documentos relacionados

  1. The Relevance of a Diagnostic and Counseling Service for People Living With HTLV-1/2 in a Metropolis of the Brazilian Amazon.
  2. Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.
  3. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
  4. Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay.
  5. Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon.
  6. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  7. Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
  8. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
  9. Human T-lymphotropic virus type 1 and aspergillosis: an invisible co-infection.
  10. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.